Large-scale testing (Phase 3)Study completedNCT00190593What this trial is testingRaloxifene Use for The HeartWho this might be right forCardiovascular DiseasesBreast Neoplasms Eli Lilly and Company 10,000
Testing effectiveness (Phase 2)Study completedNCT00001848What this trial is testingThe Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by EndometriosisWho this might be right forEndometriosisPelvic Pain Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612
Post-approval studies (Phase 4)Study completedNCT00191425What this trial is testing2-Year Therapy With Teriparatide vs 1-yr Therapy Followed by 1-Year of Raloxifene or Calcium/Vit D in Severe Postmenopausal OsteoporosisWho this might be right forOsteoporosis, Postmenopausal Eli Lilly and Company 810
Large-scale testing (Phase 3)Active Not RecruitingNCT06062810What this trial is testingPharmacogenomics ANDA SNP Clinical Study - Raloxifene and Single Nucleotide PolymorphismsWho this might be right forBreast Cancer Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair 600
Post-approval studies (Phase 4)Study completedNCT00371956What this trial is testingRaloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid TherapyWho this might be right forOsteoporosis Tuen Mun Hospital 114
Post-approval studies (Phase 4)UnknownNCT03006003What this trial is testingOsteoporosis Treatment in Post-menopausal WomenWho this might be right forDepressive Syndrome Taichung Veterans General Hospital 500
Testing effectiveness (Phase 2)Study completedNCT00206557What this trial is testingThe Use of Selective Estrogen Receptor Modulators in the Treatment of Schizophrenia- a Pilot StudyWho this might be right forSchizophreniaSchizoaffective DisorderSchizophreniform Disorder The Alfred 60
Large-scale testing (Phase 3)Study completedNCT00065767What this trial is testingCognitive and Neurophysiological Effects of Raloxifene in Alzheimer's DiseaseWho this might be right forAlzheimer Disease University of Wisconsin, Madison 20
Testing effectiveness (Phase 2)Looking for participantsNCT06944145What this trial is testingNew Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic HyperplasiaWho this might be right forBPH (Benign Prostatic Hyperplasia)Lower Urinary Track Symptoms Beth Israel Deaconess Medical Center 242
Not applicableEnded earlyNCT01607320What this trial is testingEfficacy Study of Raloxifene to Induce Ovulation in Polycystic Ovarian SyndromeWho this might be right forPolycystic Ovarian Syndrome Bruce Lessey 3
Testing effectiveness (Phase 2)Study completedNCT00026962What this trial is testingEffects of Raloxifene on Hormone LevelsWho this might be right forBreast Cancer National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT00368459What this trial is testingRaloxifene for Women With Alzheimer's DiseaseWho this might be right forAlzheimer Disease Stanford University 42
Large-scale testing (Phase 3)Study completedNCT00383422What this trial is testingStudy Comparing Arzoxifene With Raloxifene in Women After Menopause With OsteoporosisWho this might be right forOsteoporosis, Postmenopausal Eli Lilly and Company 320
Large-scale testing (Phase 3)Study completedNCT00427700What this trial is testingInduction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian SyndromeWho this might be right forPolycystic Ovary Syndrome Hospital de Clinicas de Porto Alegre 82
Post-approval studies (Phase 4)Study completedNCT01041092What this trial is testingDouble Blind, Placebo-controlled Study of Raloxifene for Negative Symptoms of Schizophrenia in Postmenopausal WomenWho this might be right forSchizophrenia Fundació Sant Joan de Déu 34
Testing effectiveness (Phase 2)Study completedNCT00004915What this trial is testingRaloxifene in Treating Patients With Persistent or Recurrent Endometrial CancerWho this might be right forEndometrial Cancer Northwestern University
Very early researchStudy completedNCT01050842What this trial is testingBicalutamide and Raloxifene in Treating Patients With Metastatic or Hormone-Refractory Prostate CancerWho this might be right forProstate CancerAdenocarcinoma of the ProstateHormone-resistant Prostate Cancer+1 more Mayo Clinic 18
Large-scale testing (Phase 3)UnknownNCT01280305What this trial is testingRaloxifene in Treatment of Schizophrenia and Schizoaffective DisorderWho this might be right forSchizophreniaSchizoaffective Disorder Sheba Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT02517593What this trial is testingGenetic Risk Estimation of Breast Cancer Prior to Preventive Medication UptakeWho this might be right forBreast Cancer Mayo Clinic 151
Large-scale testing (Phase 3)Study completedNCT01573637What this trial is testingRaloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal WomenWho this might be right forSchizophrenia in Post Menopausal Women Fundació Sant Joan de Déu 78